CIK: 0001969764 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 12, 2025
Total Value ($000): $99,895 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PAGP | PLAINS GP HOLDINGS LP-CL | 1,272,360 | $23,208 | 23.2% | $18.82 | — | LTD PARTNR INT A | 72651A207 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 3,786,425 | $11,927 | 11.9% | $3.48 | -21.2% | COM | 004468500 |
| — | AKERO THERAPEUTICS INC | 228,884 | $10,867 | 10.9% | $24.86 | — | COM | 00973Y108 |
| MIST | MILESTONE PHARMACEUTICALS | 5,124,890 | $10,250 | 10.3% | $1.80 | -2.1% | COM | 59935V107 |
| — | APPLIED THERAPEUTICS INC | 11,285,420 | $6,827 | 6.8% | $2.53 | — | COM | 03828A101 |
| PHAT | PHATHOM PHARMACEUTICALS I | 552,927 | $6,508 | 6.5% | $8.64 | +19.4% | COM | 71722W107 |
| ABEO | ABEONA THERAPEUTICS INC | 974,022 | $5,143 | 5.1% | $5.31 | +19.4% | COM NEW | 00289Y206 |
| DCTH | DELCATH SYSTEMS INC | 438,509 | $4,714 | 4.7% | $12.56 | -11.1% | COM NEW | 24661P807 |
| CLDX | CELLDEX THERAPEUTICS INC | 155,000 | $4,010 | 4.0% | $23.17 | 0.0% | COM NEW | 15117B202 |
| TCRX | TSCAN THERAPEUTICS INC | 1,932,304 | $3,517 | 3.5% | $4.58 | -61.3% | COM | 89854M101 |
| CMPS | COMPASS PATHWAYS PLC | 510,000 | $2,922 | 2.9% | $5.73 | — | SPONSORED ADS | 20451W101 |
| NKTR | NEKTAR THERAPEUTICS | 49,000 | $2,788 | 2.8% | $33.10 | 0.0% | COM NEW | 640268306 |
| JSPR | JASPER THERAPEUTICS INC | 1,028,806 | $2,449 | 2.5% | $3.03 | 0.0% | COM NEW | 471871202 |
| ZVRA | ZEVRA THERAPEUTICS INC | 231,874 | $2,205 | 2.2% | $7.08 | +41.7% | COM NEW | 488445206 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 90,000 | $1,942 | 1.9% | $18.04 | 0.0% | COM | 92790C104 |
| LONA | ATHIRA PHARMA INC | 149,279 | $618 | 0.6% | $3.92 | 0.0% | COM | 04746L203 |